Co-pay method helps drive up drug prices

Wall Street Journal

24 October 2017 - One of the biggest mistakes in health-insurance benefit design was to use fixed copayments instead of the traditional 80%/20% cost sharing between the insurer and the consumer.

None of the letters of Oct. 19 responding to Scott Atlas’s “The Health Reform That Hasn’t Been Tried” (op-ed, Oct. 4) touch on the cost of pharmaceuticals.

One of the biggest mistakes in health-insurance benefit design that was made decades ago was to use fixed copayments and move away from traditional 80%/20% cost sharing between the insurer and the consumer.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder